The AmoyDx® HRR Liquid NGS Panel is an advanced next-generation sequencing (NGS) assay designed for the qualitative detection of single nucleotide variants (SNVs) and insertions/deletions (InDels) within the protein-coding regions and intron/exon boundaries of 24 critical genes. These include ATM, ATR, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK1, CHEK2, FANCA, FANCL, HDAC2, MLH1, MRE11, NBN, PALB2, RAD51B, RAD51C, RAD51D, RAD54L, PIK3CA, PTEN, AKT1, and AR.
The test uses circulating cell-free DNA (cfDNA) extracted from plasma obtained from anti-coagulated peripheral whole blood samples. This assay provides a minimally invasive solution for analyzing HRR-related genetic alterations, supporting the study of precision oncology and guiding treatment strategies.
Liquid Biopsy Complement Tissue Biopsy in Prostate Cancer
Offering Comprehensive Insights into Pivotal Biomarkers for mCRPC
Mutations( Hover over each mutational type to highlight genes covered )
All
ATM
ATM
SNV/INDELS
ATR
ATR
SNV/INDELS
BARD1
BARD1
SNV/INDELS
BRCA1
BRCA1
SNV/INDELS
BRCA2
BRCA2
SNV/INDELS
BRIP1
BRIP1
SNV/INDELS
CDK12
CDK12
SNV/INDELS
CHEK1
CHEK1
SNV/INDELS
CHEK2
CHEK2
SNV/INDELS
FANCA
FANCA
SNV/INDELS
FANCL
FANCL
SNV/INDELS
HDAC2
HDAC2
SNV/INDELS
MLH1
MLH1
SNV/INDELS
MRE11
MRE11
SNV/INDELS
NBN
NBN
SNV/INDELS
PALB2
PALB2
SNV/INDELS
PIK3CA
PIK3CA
SNV/INDELS
RAD51B
RAD51B
SNV/INDELS
RAD51C
RAD51C
SNV/INDELS
RAD51D
RAD51D
SNV/INDELS
RAD54L
RAD54L
SNV/INDELS
PTEN
PTEN
SNV/INDELS
AKT1
AKT1
SNV/INDELS
AR
AR
SNV/INDELS
Specifications
Kit format
24 reactions/kit
Target regions
Whole coding regions of 24 genes
Sample type
Plasma cfDNA
Instrument
NovaSeq 6000, NextSeq 500, NextSeq 550, NextSeq 550Dx (RUO mode) MiSeq, MiSeqDx (RUO mode) and MiniSeq
Inquiry